神経梅毒の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR4105)
◆英語タイトル:Global Neurosyphilis Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR4105
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:91
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥499,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥748,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、神経梅毒の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(無症候性神経梅毒、髄膜神経梅毒、髄膜血管神経梅毒、その他)、用途別市場規模(病院&診療所、医学研究センター、学術研究機関)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・神経梅毒の市場動向
・企業の競争状況、市場シェア
・神経梅毒の種類別市場規模(無症候性神経梅毒、髄膜神経梅毒、髄膜血管神経梅毒、その他)
・神経梅毒の用途別市場規模(病院&診療所、医学研究センター、学術研究機関)
・神経梅毒の北米市場規模2016-2027(アメリカ、カナダ)
・神経梅毒の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・神経梅毒のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・神経梅毒の中南米市場規模2016-2027(メキシコ、ブラジル)
・神経梅毒の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott、Bayer、Eli Lilly and Company、GlaxoSmithKline、Novartis、Pfizer、Sanofi)
・結論
【レポートの概要】

Neurosyphilis is an infection of the brain or spinal cord caused by the spirochete Treponema pallidum. It usually occurs in people who have had chronic, untreated syphilis, usually about 10 to 20 years after first infection and develops in about 25%–40% of those who are not treated. The United States’ Centers for Disease Control and Prevention (CDC) advises that neurosyphilis can occur at any stage of a syphilis infection.
Neurosyphilis has four different forms: asymptomatic, meningovascular, tabes dorsalis, and general paresis. In rare instances, active neurosyphilis can mimic Alzheimer’s disease. In addition to evaluation of any symptoms and signs, various blood tests can be done. Additional tests to look for problems with the nervous system may include Cerebral angiogram, Head CT scan, Lumbar puncture and MRI scan of the brain, brainstem, or spinal cord.

Market Analysis and Insights: Global Neurosyphilis Market
The global Neurosyphilis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neurosyphilis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neurosyphilis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neurosyphilis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neurosyphilis market.

Global Neurosyphilis Scope and Market Size
Neurosyphilis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neurosyphilis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Asymptomatic Neurosyphilis
Meningeal Neurosyphilis
Meningovascular Neurosyphilis
Others

Segment by Application
Hospital & Clinics
Medical Research Centers
Academic Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Bayer
Eli Lilly and Company
GlaxoSmithKline
Novartis
Pfizer
Sanofi

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurosyphilis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Asymptomatic Neurosyphilis
1.2.3 Meningeal Neurosyphilis
1.2.4 Meningovascular Neurosyphilis
1.2.5 Others
1.3 Market by Application
1.3.1 Global Neurosyphilis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Clinics
1.3.3 Medical Research Centers
1.3.4 Academic Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Neurosyphilis Market Perspective (2016-2027)
2.2 Neurosyphilis Growth Trends by Regions
2.2.1 Neurosyphilis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neurosyphilis Historic Market Share by Regions (2016-2021)
2.2.3 Neurosyphilis Forecasted Market Size by Regions (2022-2027)
2.3 Neurosyphilis Industry Dynamic
2.3.1 Neurosyphilis Market Trends
2.3.2 Neurosyphilis Market Drivers
2.3.3 Neurosyphilis Market Challenges
2.3.4 Neurosyphilis Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Neurosyphilis Players by Revenue
3.1.1 Global Top Neurosyphilis Players by Revenue (2016-2021)
3.1.2 Global Neurosyphilis Revenue Market Share by Players (2016-2021)
3.2 Global Neurosyphilis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neurosyphilis Revenue
3.4 Global Neurosyphilis Market Concentration Ratio
3.4.1 Global Neurosyphilis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurosyphilis Revenue in 2020
3.5 Neurosyphilis Key Players Head office and Area Served
3.6 Key Players Neurosyphilis Product Solution and Service
3.7 Date of Enter into Neurosyphilis Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Neurosyphilis Breakdown Data by Type
4.1 Global Neurosyphilis Historic Market Size by Type (2016-2021)
4.2 Global Neurosyphilis Forecasted Market Size by Type (2022-2027)

5 Neurosyphilis Breakdown Data by Application
5.1 Global Neurosyphilis Historic Market Size by Application (2016-2021)
5.2 Global Neurosyphilis Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Neurosyphilis Market Size (2016-2027)
6.2 North America Neurosyphilis Market Size by Type
6.2.1 North America Neurosyphilis Market Size by Type (2016-2021)
6.2.2 North America Neurosyphilis Market Size by Type (2022-2027)
6.2.3 North America Neurosyphilis Market Size by Type (2016-2027)
6.3 North America Neurosyphilis Market Size by Application
6.3.1 North America Neurosyphilis Market Size by Application (2016-2021)
6.3.2 North America Neurosyphilis Market Size by Application (2022-2027)
6.3.3 North America Neurosyphilis Market Size by Application (2016-2027)
6.4 North America Neurosyphilis Market Size by Country
6.4.1 North America Neurosyphilis Market Size by Country (2016-2021)
6.4.2 North America Neurosyphilis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Neurosyphilis Market Size (2016-2027)
7.2 Europe Neurosyphilis Market Size by Type
7.2.1 Europe Neurosyphilis Market Size by Type (2016-2021)
7.2.2 Europe Neurosyphilis Market Size by Type (2022-2027)
7.2.3 Europe Neurosyphilis Market Size by Type (2016-2027)
7.3 Europe Neurosyphilis Market Size by Application
7.3.1 Europe Neurosyphilis Market Size by Application (2016-2021)
7.3.2 Europe Neurosyphilis Market Size by Application (2022-2027)
7.3.3 Europe Neurosyphilis Market Size by Application (2016-2027)
7.4 Europe Neurosyphilis Market Size by Country
7.4.1 Europe Neurosyphilis Market Size by Country (2016-2021)
7.4.2 Europe Neurosyphilis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Neurosyphilis Market Size (2016-2027)
8.2 Asia-Pacific Neurosyphilis Market Size by Type
8.2.1 Asia-Pacific Neurosyphilis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neurosyphilis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neurosyphilis Market Size by Type (2016-2027)
8.3 Asia-Pacific Neurosyphilis Market Size by Application
8.3.1 Asia-Pacific Neurosyphilis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neurosyphilis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neurosyphilis Market Size by Application (2016-2027)
8.4 Asia-Pacific Neurosyphilis Market Size by Region
8.4.1 Asia-Pacific Neurosyphilis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neurosyphilis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Neurosyphilis Market Size (2016-2027)
9.2 Latin America Neurosyphilis Market Size by Type
9.2.1 Latin America Neurosyphilis Market Size by Type (2016-2021)
9.2.2 Latin America Neurosyphilis Market Size by Type (2022-2027)
9.2.3 Latin America Neurosyphilis Market Size by Type (2016-2027)
9.3 Latin America Neurosyphilis Market Size by Application
9.3.1 Latin America Neurosyphilis Market Size by Application (2016-2021)
9.3.2 Latin America Neurosyphilis Market Size by Application (2022-2027)
9.3.3 Latin America Neurosyphilis Market Size by Application (2016-2027)
9.4 Latin America Neurosyphilis Market Size by Country
9.4.1 Latin America Neurosyphilis Market Size by Country (2016-2021)
9.4.2 Latin America Neurosyphilis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Neurosyphilis Market Size (2016-2027)
10.2 Middle East & Africa Neurosyphilis Market Size by Type
10.2.1 Middle East & Africa Neurosyphilis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neurosyphilis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neurosyphilis Market Size by Type (2016-2027)
10.3 Middle East & Africa Neurosyphilis Market Size by Application
10.3.1 Middle East & Africa Neurosyphilis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neurosyphilis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neurosyphilis Market Size by Application (2016-2027)
10.4 Middle East & Africa Neurosyphilis Market Size by Country
10.4.1 Middle East & Africa Neurosyphilis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neurosyphilis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Neurosyphilis Introduction
11.1.4 Abbott Revenue in Neurosyphilis Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Neurosyphilis Introduction
11.2.4 Bayer Revenue in Neurosyphilis Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Neurosyphilis Introduction
11.3.4 Eli Lilly and Company Revenue in Neurosyphilis Business (2016-2021)
11.3.5 Eli Lilly and Company Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Neurosyphilis Introduction
11.4.4 GlaxoSmithKline Revenue in Neurosyphilis Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Neurosyphilis Introduction
11.5.4 Novartis Revenue in Neurosyphilis Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Neurosyphilis Introduction
11.6.4 Pfizer Revenue in Neurosyphilis Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Neurosyphilis Introduction
11.7.4 Sanofi Revenue in Neurosyphilis Business (2016-2021)
11.7.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 神経梅毒の世界市場規模・現状・予測2021年-2027年(Global Neurosyphilis Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。